MedPath

GnRH antagonist administration for patients at high risk of severe Ovarian Hyperstimulation Syndrome (OHSS) down regulated GnRH agonist

Completed
Conditions
Ovarian Hyperstimulation Syndrome (OHSS)
Urological and Genital Diseases
Complications associated with artificial fertilization
Registration Number
ISRCTN58806684
Lead Sponsor
The Egyptian IVF-ET Centre (Egypt)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
216
Inclusion Criteria

Women undergoing in vitro fertilisation (IVF) or IntraCytoplasmic Sperm Injection (ICSI) trial down regulated with GnRH agonist and at risk of severe OHSS

Exclusion Criteria

1. Women above 39 years old
2. Medical illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath